Skip to main content
Caplight Logo









inne

inne

Private
BerlinHealthcare & Life Scienceshttps://inne.io/

Last Round

Series A

Extension

May 25, 2022

Total Funding Raised

$18.9M

Company Overview

inne is a healthtech company that provides an at-home fertility monitoring system using saliva-based biosensors to track hormone levels.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Health IoT, Subscription Commerce, Sensors

Business Model

B2C

Customer Profile

Hardware + Subscription

AI Layer

Application

Keywords

femtechfertility monitoringhormone-free contraceptionat-home diagnosticsprogesterone testingnatural family planningcycle trackingbiosensorovulation trackerD2C healthhealth IoTsubscription commercedigital healthperiod trackerfertility awareness method

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

inne Comparables

Compare inne with similar companies based on industry and business-model similarity.

inne comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
trackle
84%
Eli Health
84%
Natural Cycles
83%

inne Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 25, 2022
Series AOct 31, 2019

Key People

Founding team and executive leadership

Eirini Rapti

Co-Founder, CEO

Founding Team

Hicham J. Ratnani

Co-CEO

Executive Team

inne Investors

Notable investors and investment history

inne investors
InvestorRounds
Blossom CapitalSeries A
Calm/Storm VenturesSeries A Extension
Monkfish EquitySeries A
DSM VenturingSeries A Extension
StartGreen CapitalSeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2025

    Saliva-based contraceptive method certified under IVDR in 2025.

  • May 25, 2022

    $10M round led by DSM Venturing.

inne Filings

Explore SEC and related filing metadata, where available.

inne filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about inne's valuation, stock price, and market status.

Is inne a public or private company?

inne is a private company.

What is the current stock price of inne?

inne is a private company with no public stock price. No recent secondary market data is available.

How much is inne worth (valuation)?

Valuation information for inne is not publicly available.

Can I buy inne stock?

inne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was inne's last funding round?

inne's most recent funding round was Series A Extension on May 25, 2022.

Who are the main investors in inne?

Key investors in inne include Blossom Capital, DSM Venturing.

Will inne IPO soon?

No public IPO plans have been announced for inne.

How can I track inne secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor inne's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBerlin
Employee Range31
Year Founded2016
Last FundingMay 25, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?